Li; Xuhang

Patent Applications and Registrations

Patent applications and USPTO patent grants for Li; Xuhang.The latest application filed is for "methods of treating inflammatory bowel disease with amd3100 and tacrolimus".

Company Profile

7.9.18

Li; Xuhang - Clarksville MD
Li; Xuhang - Baltimore MD

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Methods Of Treating Inflammatory Bowel Disease With Amd3100 And Tacrolimus App 20220184043 - Sun; Zhaoli ; et al.	2022-06-16
Methods of treating inflammatory bowel disease with AMD3100 and Tacrolimus Grant 11,291,657 - Sun , et al. April 5, 2	2022-04-05
nAChR-alpha7 Agonists and nAChR-alpha7 Antagonists for Treating Ulcerative Colitis (UC) and Crohn's Disease (CD) App 20210177816 - Li; Xuhang ; et al.	2021-06-17
Methods for treating inflammatory bowel disease using prostate specific membrane antigen (PSMA) inhibitors Grant 10,849,915 - Slusher , et al. December 1, 2	2020-12-01
Compositions and methods for diagnosing and treating inflammatory bowel disease and related disorders Grant 10,730,916 - Li , et al.	2020-08-04
In vitro pre-conditioned bone marrow-derived mesenchymal stem cells and uses thereof Grant 10,709,740 - Li , et al.	2020-07-14
Methods Of Treating Inflammatory Bowel Disease With Amd3100 And Tacrolimus App 20200038381 - Sun; Zhaoli ; et al.	2020-02-06
Vitro Pre-conditioned Bone Marrow-derived Mesenchymal Stem Cells And Uses Thereof App 20190358267 - LI; Xuhang ; et al.	2019-11-28
In vitro pre-conditioned bone marrow-derived mesenchymal stem cells and uses thereof Grant 10,478,458 - Li , et al. Nov	2019-11-19
Methods Of Treating Inflammatory Bowel Disease With Amd3100 And Tacrolimus App 20190314344 - Sun; Zhaoli ; et al.	2019-10-17
Methods of treating inflammatory bowel disease with AMD3100 and tacrolimus Grant 10,420,751 - Sun , et al. Sept	2019-09-24
Methods For Treating Inflammatory Bowel Disease Using Prostate Specific Membrane Antigen (psma) Inhibitors App 20190076447 - Slusher; Barbara ; et al.	2019-03-14
Methods for treating inflammatory bowel disease using prostate specific membrane antigen (PSMA) inhibitors Grant 10,172,873 - Slusher , et al. J	2019-01-08
Methods For Treating Inflammatory Bowel Disease Using Prostate Specific Membrane Antigen (psma) Inhibitors App 20170224709 - SLUSHER; BARBARA ; et al.	2017-08-10
In Vitro Pre-conditioned Bone Marrow-derived Mesenchymal Stem Cells And Uses Thereof App 20170095511 - LI; Xuhang ; et al.	2017-04-06
Methods For Diagnosis And Prognosis Of Inflammatory Bowel Disease Using Cytokine Profiles App 20170059581 - Li; Xuhang ; et al.	2017-03-02
Compositions And Methods For Diagnosing And Treating Inflammatory Bowel Disease And Related Disorders App 20160370381 - Li; Xuhang ; et al.	2016-12-22
Compositions and methods for diagnosing and treating inflammatory bowel disease and related disorders Grant 9,434,771 - Li , et al. September 6, 2	2016-09-06
Compositions And Methods For Treating Inflammatory Bowel Disease App 20160008331 - Sun; Zhaoli ; et al.	2016-01-14
Cytokine Profiles As Methods For Diagnosis And Prognosis Of Irritable Bowel Syndrome App 20140128276 - Li; Xuhang ; et al.	2014-05-08
Methods For Diagnosis And Prognosis Of Inflammatory Bowel Disease Using Cytokine Profiles App 20130303391 - Li; Xuhang ; et al.	2013-11-14
nAChRalpha7 Agonists and nAChRalpha7 Antagonists for Treating Ulcerative Colitis (UC) and Crohn's Disease (CD) App 20130197028 - Li; Xuhang ; et al.	2013-08-01
Compositions And Methods For Diagnosing And Treating Inflammatory Bowel Disease And Related Disorders App 20110251100 - Li; Xuhang ; et al.	2011-10-13

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.